The store will not work correctly when cookies are disabled.
2-(8-hydroxyquinolin-2-yl)-3-(2-methoxyphenyl)thiazolidin-4-one
ID: ALA4743353
PubChem CID: 162646150
Max Phase: Preclinical
Molecular Formula: C19H16N2O3S
Molecular Weight: 352.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccccc1N1C(=O)CSC1c1ccc2cccc(O)c2n1
Standard InChI: InChI=1S/C19H16N2O3S/c1-24-16-8-3-2-6-14(16)21-17(23)11-25-19(21)13-10-9-12-5-4-7-15(22)18(12)20-13/h2-10,19,22H,11H2,1H3
Standard InChI Key: PNQHKTCQJQECIK-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
28.1215 -18.3744 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1204 -19.1939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8284 -19.6029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8266 -17.9655 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5352 -18.3708 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5360 -19.1898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2445 -19.5969 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.9528 -19.1860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.9481 -18.3639 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2390 -17.9606 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8303 -20.4201 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6662 -19.5890 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.7549 -20.4014 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.5548 -20.5682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.9607 -19.8589 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4115 -19.2538 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.1514 -20.9480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3725 -20.6969 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7677 -21.2454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9405 -22.0450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7235 -22.2932 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3250 -21.7432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8901 -21.3134 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.1038 -21.9905 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.2790 -22.7887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
22 24 1 0
24 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 352.42 | Molecular Weight (Monoisotopic): 352.0882 | AlogP: 3.73 | #Rotatable Bonds: 3 |
Polar Surface Area: 62.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 3.11 | CX LogD: 3.10 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.78 | Np Likeness Score: -0.60 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |